STOCK TITAN

Intuitive Surgical Inc - ISRG STOCK NEWS

Welcome to our dedicated news page for Intuitive Surgical (Ticker: ISRG), a resource for investors and traders seeking the latest updates and insights on Intuitive Surgical.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Intuitive Surgical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Intuitive Surgical's position in the market.

Rhea-AI Summary
Intuitive (ISRG) reported strong financial results for Q4 2023, with a 17% increase in revenue to $1.93 billion. The company also saw a 21% growth in da Vinci procedures and placed 415 da Vinci surgical systems, leading to a 14% increase in the installed base. GAAP net income was $606 million, and non-GAAP net income was $574 million. The company obtained CE mark certification for the da Vinci single-port surgical system, planning to commercialize it in select major European countries throughout 2024. The impact of the COVID-19 pandemic on the company's procedure volumes was minimal in Q4 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.36%
Tags
earnings
-
Rhea-AI Summary
Intuitive Surgical, Inc. (ISRG) announced unaudited preliminary fourth quarter and full year 2023 financial results. Fourth quarter 2023 worldwide da Vinci procedures grew approximately 21% compared with the fourth quarter of 2022. Full year 2023 worldwide da Vinci procedures grew approximately 22% compared with 2022. Preliminary fourth quarter 2023 revenue of approximately $1.93 billion increased 17% compared with $1.66 billion in the fourth quarter of 2022. Preliminary 2023 revenue of approximately $7.12 billion increased 14% compared with $6.22 billion in 2022. The Company expects worldwide da Vinci procedures to increase approximately 13% to 16% in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.25%
Tags
earnings
-
Rhea-AI Summary
Intuitive, a global technology leader in minimally invasive care and robotic-assisted surgery, has appointed Sreelakshmi Kolli, EVP and CDO at Align Technology, to its board of directors. Kolli brings expertise in technology, business growth, and strategy. She will provide insights on digital capabilities and customer experiences in advancing minimally invasive care. With Kolli's addition, the board of directors will expand to 12 members.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.14%
Tags
management
Rhea-AI Summary
Intuitive announces Q3 financial results with strong growth in da Vinci procedures and revenue
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.75%
Tags
earnings
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.16%
Tags
earnings
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.47%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.79%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.88%
Tags
earnings
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.5%
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.2%
Tags
none
Intuitive Surgical Inc

Nasdaq:ISRG

ISRG Rankings

ISRG Stock Data

136.16B
350.10M
0.53%
88.89%
0.84%
Surgical Appliance and Supplies Manufacturing
Manufacturing
Link
US
Sunnyvale

About ISRG

Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the NASDAQ-100 and S&P 500.